Lipo-C (No B12)

Research · Lipo-C (No B12)

Overview

Lipo-C (No B12) is a lipotropic formulation combining methionine, inositol, choline, and L-carnitine without cobalamin. Methionine is an essential sulfur amino acid and precursor of S-adenosylmethionine; inositol is a cyclic polyol forming the head group of phosphoinositide lipids; choline is a precursor of phosphatidylcholine and acetylcholine; and L-carnitine is a carrier for long-chain fatty acids. The term lipotropic historically refers to compounds characterized in hepatic lipid export research. Each component has an independent biochemical literature, which forms the basis for describing the formulation.

Mechanism of action

Each component acts through a distinct pathway. Methionine is converted to S-adenosylmethionine, which donates methyl groups for numerous reactions, including hepatic phosphatidylcholine synthesis via PEMT, and feeds the transsulfuration pathway toward cysteine. Choline is phosphorylated and incorporated into phosphatidylcholine through the CDP-choline pathway, required for VLDL assembly and hepatic lipid export, and is also oxidized to betaine, an alternative methyl donor. Myo-inositol is incorporated into phosphatidylinositol and its phosphorylated derivatives involved in intracellular signaling. L-carnitine shuttles long-chain acyl groups into mitochondria via the CPT1/CPT2 system for beta-oxidation. In the absence of cobalamin, methionine regeneration from homocysteine in this formulation context depends on endogenous cofactor supply and on the betaine-homocysteine methyltransferase route supported by choline-derived betaine.

Key research findings

1. 01

   Rodent dietary studies established that choline and methionine deficiency produce hepatic lipid accumulation, the original basis of the lipotropic concept.

2. 02

   Controlled human feeding studies have characterized choline requirements and the liver and muscle dysfunction that develops under dietary choline restriction.

3. 03

   Biochemical research has characterized myo-inositol metabolism and its incorporation into inositol phospholipids and second-messenger signaling.

4. 04

   The combined formulation has not been characterized as a single entity in peer-reviewed studies; published literature addresses the components individually.

Published references

• A brief history of choline

  Zeisel SH — Ann Nutr Metab, 2012 · PMID: 23183298

• Metabolism and function of myo-inositol and inositol phospholipids

  Holub BJ — Annu Rev Nutr, 1986 · PMID: 2425833

The information above is derived from published preclinical and clinical research. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.